In recent years, scientists have been exploring unexpected links between human proteins involved in the body’s defense mechanisms and certain bacterial immune proteins. Focusing on conserved immune domains originating....
Aalpelisib has now been approved by the European Medicines Agency for the treatment of severe forms of PIK3CA-related overgrowth spectrum (PROS), including CLOVES syndrome. This therapeutic breakthrough is the....
